BioPharma Drug Discovery
XtalPi Launches AI-Powered Kodexia Platform to Accelerate siRNA Drug Discovery
This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property...
October 08, 2026 | News
QIAGEN Expands AI Push with New Tools for Biological Research and Drug Discovery
New IPA Investigator lets researchers ask biological questions in natural language and examine the scientific evidence behind the results New QIAGEN D...
October 08, 2026 | News
Thermo Fisher Proteomics Study Uncovers Over 2,500 New Genetic-Protein Associations
Thermo Fisher’s complementary proteomic technologies uncovered more than 2,500 new biological associations: Initial findings from the PRECISE-SG100...
October 06, 2026 | News
CSL, Alentis Forge $1.55B Partnership to Advance Lixudebart for Kidney and Liver Diseases
Alentis to receive US$355 million initial payment and up to US$1.2 billion in commercial milestones, with global profits shared CSL and Alentis Therapeuti...
October 06, 2026 | News
FDA Expands Lilly’s Jaypirca Approval to First-Line CLL/SLL Treatment
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved an additional indication for Jaypirca (pirto...
October 06, 2026 | News
Rznomics Secures Positive EMA Opinion for Orphan Designation of RZ-001 in Glioma
Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that the European Medicines Agency's (EMA...
October 02, 2026 | News
Piramal and NP2 Advance Generic Cancer Drug Cyclophosphamide Towards US Manufacturing
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturi...
October 02, 2026 | News
CAS and Novartis Partner to Build AI-Ready Reaction Data Platform for Drug Discovery
Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data discovery and analysis ...
October 01, 2026 | News
Piramal Pharma Invests $5.3M to Expand Drug Substance Manufacturing in Canada
Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure. With its investment throug...
October 01, 2026 | Analysis
Lilly’s Retatrutide Delivers 20.8% Weight Loss in Phase III Obesity and Type 2 Diabetes Trial
In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over 80 weeks, with more than half...
October 01, 2026 | News
China Approves Jaypirca Across All Lines of Therapy for CLL/SLL
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...
September 30, 2026 | News
iRegene Advances Off-the-Shelf Retinal Cell Therapy Into Clinical Trials in US and China
Following its Parkinson's disease program, iRegene advances another off-the-shelf cell therapy into clinical development in the U.S. and China. iReg...
September 30, 2026 | News
Leo Cancer Care Advances Upright Radiation Therapy Experience for Children
Leo Cancer Care has announced plans to further invest in the treatment experience for children undergoing radiation therapy. Following the world's fi...
September 29, 2026 | News
XtalPi Files US FDA IND for AI-Designed Gut-Restricted Pan-TRK Inhibitor KQTD-126
This milestone marks the first IND submission from XtalPi's proprietary pipeline, recently unveiled in its interim results, validating the company's ...
September 28, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
